Excelimmune
Excelimmune, Inc.: A US-based biopharmaceutical firm developing therapeutic antibodies for various diseases.
Founded
2006Excelimmune, Inc.: A US-based biopharmaceutical firm developing therapeutic antibodies for various diseases.
Excelimmune, Inc. is a biopharmaceutical company founded with the mission to develop innovative antibody treatments for a range of diseases, including infectious diseases, protein disorders, and cancer. The company's vision is to leverage advanced biotechnological methods to create effective therapeutic solutions that address unmet medical needs. Excelimmune offers products such as AffiVET® Rapid Test Kits for poultry avian influenza surveillance and cell immortalization kits, focusing on both human and veterinary health markets.
Notable figures associated with Excelimmune include key researchers and biotechnologists who have contributed significantly to the field of therapeutic antibodies. The company has attracted investment from various venture capital firms specializing in biotech innovations. Excelimmune has achieved several milestones, including the development of proprietary antibody treatments and diagnostic kits that have had a substantial impact on disease management and prevention. Their contributions are recognized for advancing both human and animal health, reflecting their commitment to improving global health outcomes.
Companies similar to Excelimmune include ImmuneXcite, Celldex Therapeutics, ImmuneID and Inimmune.
Excelimmune was founded in 2006.
Excelimmune's headquarters is located in Woburn, MA, US.
Excelimmune's most recent funding round was for $6M (USD) in January 2012.
As of Jan 3, 2012, Excelimmune has raised a total of $36M (USD).
Excelimmune has 30 employees as of Feb 5, 2024.
